Literature DB >> 29405430

TFM classification and staging of oral submucous fibrosis: A new proposal.

Gururaj Arakeri1,2, Deepak Thomas3, Abdulsalam S Aljabab1,4, Santosh Hunasgi5, Kirthi Kumar Rai6, Beverley Hale7, Felipe Paiva Fonseca8, Ricardo Santiago Gomez8, Siavash Rahimi9,10, Matthias A W Merkx2, Peter A Brennan3.   

Abstract

BACKGROUND: We have evaluated the rationale of existing grading and staging schemes of oral submucous fibrosis (OSMF) based on how they are categorized. A novel classification and staging scheme is proposed.
METHODS: A total of 300 OSMF patients were evaluated for agreement between functional, clinical, and histopathological staging. Bilateral biopsies were assessed in 25 patients to evaluate for any differences in histopathological staging of OSMF in the same mouth. Extent of clinician agreement for categorized staging data was evaluated using Cohen's weighted kappa analysis. Cross-tabulation was performed on categorical grading data to understand the intercorrelation, and the unweighted kappa analysis was used to assess the bilateral grade agreement. Probabilities of less than 0.05 were considered significant. Data were analyzed using SPSS Statistics (version 25.0, IBM, USA).
RESULTS: A low agreement was found between all the stages depicting the independent nature of trismus, clinical features, and histopathological components (K = 0.312, 0.167, 0.152) in OSMF. Following analysis, a three-component classification scheme (TFM classification) was developed that describes the severity of each independently, grouping them using a novel three-tier staging scheme as a guide to the treatment plan.
CONCLUSION: The proposed classification and staging could be useful for effective communication, categorization, and for recording data and prognosis, and for guiding treatment plans. Furthermore, the classification considers OSMF malignant transformation in detail.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  TFM classification; TFM staging; malignant transformation; oral submucous fibrosis; potentially malignant disorder

Mesh:

Year:  2018        PMID: 29405430     DOI: 10.1111/jop.12689

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  4 in total

1.  Evaluation of Hematological profile in Oral Submucous Fibrosis: A Cross-sectional Study.

Authors:  Deepa Jatti Patil; Manjiri Joshi
Journal:  J Oral Maxillofac Pathol       Date:  2021-01-09

2.  Evaluation of Hematological Profile in Oral Submucous Fibrosis.

Authors:  Mohammed Abidullah; Kavitha Gaddikeri; Bushra Anjum; Swapneel Vairagare; Kulkarni Tarani; Swetcha Seethamsetty
Journal:  Cureus       Date:  2022-02-05

Review 3.  Oral Potentially Malignant Disorders: Etiology, Pathogenesis, and Transformation Into Oral Cancer.

Authors:  Pratima Kumari; Priyanka Debta; Anshuman Dixit
Journal:  Front Pharmacol       Date:  2022-04-20       Impact factor: 5.988

4.  Serum uric acid levels in patients with oral cancer, leukoplakia and submucous fibrosis: a cross-sectional study.

Authors:  Karthik D Yadav; Bharati A Patil; Syed Ahmed Raheel; Abdulwahab Abuderman; Shankargouda Patil; Kamis Gaballah; Omar Kujan
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.